Clinical Trial Update: Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

View source ↗

Summary

A clinical trial registry entry outlines evaluating lecanemab at various doses for Alzheimer's disease in real-world practice; the study status is NOT_YET_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment Due to Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Alzheimer Disease (AD), Alzheimer Dementia | Status: NOT_YET_RECRUITING